ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

DTIL Precision BioSciences Inc

9.82
-0.41 (-4.01%)
Apr 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 33,626
Bid Price 9.71
Ask Price 11.00
News -
Day High 10.35

Low
8.25

52 Week Range

High
27.90

Day Low 9.785
Company Name Stock Ticker Symbol Market Type
Precision BioSciences Inc DTIL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.41 -4.01% 9.82 20:00:00
Open Price Low Price High Price Close Price Prev Close
10.19 9.785 10.35 9.82 10.23
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
446 33,626 $ 10.02 $ 336,927 - 8.25 - 27.90
Last Trade Time Type Quantity Stock Price Currency
17:53:08 1 $ 10.24 USD

Precision BioSciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
39.95M 4.06M - 48.73M -61.32M -15.09 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Precision BioSciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No DTIL Message Board. Create One! See More Posts on DTIL Message Board See More Message Board Posts

Historical DTIL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week11.7912.009.150110.62108,521-1.97-16.71%
1 Month12.8015.979.150113.38130,514-2.98-23.28%
3 Months11.51119.42999.150112.30266,026-1.69-14.69%
6 Months9.0019.42998.2512.11969,2130.829.11%
1 Year27.3027.908.2514.12915,935-17.48-64.03%
3 Years279.00431.408.2572.92929,119-269.18-96.48%
5 Years412.50710.1068.25144.67821,240-402.68-97.62%

Precision BioSciences Description

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food out of which the Therapeutics segment act as a key revenue driver for the firm.

Your Recent History

Delayed Upgrade Clock